Based on 1 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$36.60
+690.5% upside
Average target across 1 active firms as of Nov 19, 2026 vs $4.63 current
Highest Target$36.60
Average Target$36.60
Lowest Target$36.60
SBS analyst recommendation trends
86420
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Strong BuyBuyNeutralSellStrong Sell
RATING
JUN
JUL
AUG
SEP
OCT
NOV
Strong Buy
0
0
0
0
0
0
Buy
1
1
1
1
1
1
Neutral
0
0
0
0
0
0
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
1
1
1
1
1
1
As of Nov 19, 2026, 1 of 1 active firms rate SBS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
SBS EPS & revenue forecast
EPS · NEXT QUARTER
$0.10
Range $0.10 – $0.10 · 1 analysts · +10% YoY
Next period, 1 analysts expect Companhia de Saneamento Basico do Estado de Sao Paulo SABESP ADR to earn $0.10 a share (range $0.10 – $0.10), versus $0.09 a year earlier. Full-year consensus is $0.26, growing to $0.39 the year after.
REVENUE · NEXT QUARTER
$7.7B
Range $7.1B – $8.2B · 1 analysts · +22% YoY
Revenue is expected to reach $7.7B (range $7.1B – $8.2B), +21.6% year-over-year. Full-year consensus is $25.3B, rising to $30.0B next year.
Top analysts covering Companhia de Saneamento Basico do Estado de Sao Paulo SABESP ADR
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SBS.
#1
Bruno Amorim
Goldman Sachs · Rank #424
Buy
$5.73+23.8% to target
Overall win rate
32%
+ Follow
#2
AD
Alejandro Demichelis
Jefferies
Buy
$7.32+58.1% to target
Coverage
—
+ Follow
#3
GF
Gustavo Faria
Bank of America Securities
Buy
No targeton SBS
Coverage
—
+ Follow
SBS stock forecast FAQ
What is SBS's average 12-month price target?+
The 1 active firms with a live target average $36.60 for Companhia de Saneamento Basico do Estado de Sao Paulo SABESP ADR over the next 12 months, ranging from a $36.60 high to a $36.60 low, as of Nov 19, 2026.
Is SBS stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover SBS?+
1 active firms have a recognized rating on Companhia de Saneamento Basico do Estado de Sao Paulo SABESP ADR as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering SBS?+
Among analysts who currently cover SBS, Bruno Amorim of Goldman Sachs has the strongest overall Quantellect track record (Rank #424). Their current call is Buy with a $5.73 target.
What is Companhia de Saneamento Basico do Estado de Sao Paulo SABESP ADR's projected EPS for next quarter?+
The consensus estimate is $0.10 per share (range $0.10 – $0.10) across 1 analysts. Full-year EPS is projected at $0.26, rising to $0.39 the following year.
How much revenue is Companhia de Saneamento Basico do Estado de Sao Paulo SABESP ADR expected to report next quarter?+
Consensus revenue is $7.7B (range $7.1B – $8.2B). Full-year revenue is projected at $25.3B, growing to $30.0B next year.
Have analysts been upgrading or downgrading SBS lately?+
As of Nov 19, 2026, 1 of 1 active firms rate SBS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SBS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.